about
Fluoroquinolone resistance during 2000-2005: an observational study.Efficacy and safety of moxifloxacin in community acquired pneumonia: a prospective, multicenter, observational study (CAPRIVI).Moxifloxacin safety: an analysis of 14 years of clinical data.Efficacy and safety of moxifloxacin in acute exacerbations of chronic bronchitis: a prospective, multicenter, observational study (AVANTI)A brief review of moxifloxacin in the treatment of elderly patients with community-acquired pneumonia (CAP).Moxifloxacin in the management of exacerbations of chronic bronchitis and COPD.Susceptibility of oral obligate anaerobes to telithromycin, moxifloxacin and a number of commonly used antibacterials.Moxifloxacin: a respiratory fluoroquinolone
P2860
Q33337504-E5400DBA-FDF1-424B-BD44-3A84F2271545Q33929402-33876179-6FEE-4CFF-A841-7DD9603EC9D9Q34310568-99AB950C-DEF0-4403-BB65-29A16DD6DDE9Q34560033-CAC52794-2062-4308-B83A-AAE01C8CF68DQ37017387-46E55B12-8646-4F02-8056-F8292A163D3CQ37071001-6D4C8552-CDE2-4CC2-9992-98F1C244057EQ50919090-27781094-C26C-4F0B-B987-8EF1D1A6F9EBQ57778170-A2B4D33F-92EC-41E4-A6B2-410BD2AE7245
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Moxifloxacin in respiratory tract infections.
@ast
Moxifloxacin in respiratory tract infections.
@en
type
label
Moxifloxacin in respiratory tract infections.
@ast
Moxifloxacin in respiratory tract infections.
@en
prefLabel
Moxifloxacin in respiratory tract infections.
@ast
Moxifloxacin in respiratory tract infections.
@en
P2860
P356
P1476
Moxifloxacin in respiratory tract infections.
@en
P2860
P304
P356
10.1517/14656566.6.2.283
P407
P577
2005-02-01T00:00:00Z